Preserved tissue-type plasminogen activator release and endothelium- dependent vasodilation in postmenopausal women with NIDDM

Journal of Diabetes and its Complications

Volumn 14, Issue 3, 2000, Pages 127-134

  Manhem, Karin ^a   Dotevall, Annika ^a   Wilhelmsen, Lars ^a   Jern, Sverker ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Endothelium; Estrogen; t PA; Vasodilation; Women

Indexed keywords

ESTRADIOL; ESTROGEN; METHACHOLINE; MUSCARINIC RECEPTOR; NITROPRUSSIDE SODIUM; PLACEBO; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOREARM BLOOD FLOW; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN SECRETION; SEX DIFFERENCE; SHEAR STRESS; VASCULAR ENDOTHELIUM; VASODILATATION;

AGED; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; FOREARM; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; METHACHOLINE CHLORIDE; MIDDLE AGED; MUSCARINIC AGONISTS; NITROPRUSSIDE; PLETHYSMOGRAPHY; POSTMENOPAUSE; REGIONAL BLOOD FLOW; TISSUE PLASMINOGEN ACTIVATOR; VASODILATION; VASODILATOR AGENTS;

EID: 0033828217     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(00)00058-1     Document Type: Article

References (40)

1. Abbott R.D., Donahue R.P., Kannel W.B., Wilson P.W.F. The impact of diabetes on survival following myocardial infarction in men vs. women: the Framingham study. JAMA. 260:1988;3456-3460.
2. Abraham G.E., Odell W.D., Swerdloff R.S., Hopper K. Simultaneous radioimmunoassay of plasma FSH, GH, progesterone, 17-hydroxyprogesterone and 17-β estradiol during the menstrual cycle. J Clin Endocrinol Metab. 34:1995;312-316.
3. Abrams J. Role of endothelial dysfunction in coronary artery disease. Am J Cardiol. 79(12B):1997;2-9.
4. Anderson T.J., Uehata A., Gerhard M.D., Meredith I.T., Knab S., Delagrange D., Lieberman E.H., Ganz P., Creager M.A., Yeung A.C., Selwyn A.P. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 26:1995;1235-1241.
5. Avogaro A., Piarulli F., Valerio A., Miola M., Calveri M., Pavan P., Vicini P., Cobelli C., Tiengo A., Calo L., Del Prato S. Forearm nitric oxide balance, vascular relaxation, and glucose metabolism in NIDDM patients. Diabetes. 46:1997;1040-1046.
6. Barrett-Connor E.L., Cohn B.A., Wingard D.L., Edelstein S.L. Whey is diabetes mellitus stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA. 265:1991;627-631.
7. Chun B.Y., Dobson A.J., Heller R.F. The impact of diabetes on survival among patients with first myocardial infarction. Diabetes Care. 20(5):1997;704-708.
8. Clarkson P., Celermajer D., Donald A., Sampson M., Sörensen K., Adams M., Yue D.K., Betteridge D.J., Deanfield J. Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol. 28:1996;573-579.
9. Cohen R.A. Dysfunction of the vascular endothelium in diabetes mellitus. Circulation. 87(Suppl. V):1993;V67-V76.
10. Gilligan D.M., Badar D.M., Julio A., Quyyumi A.A., Cannon R.O. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. Am J Cardiol. 75:1995;264-268.
11. Gilligan D.M., Badar D.M., Panza J.A., Quyyumi A.A., Cannon R.O. Acute vascular effects of estrogen in postmenopausal women. Circulation. 90:1994;786-791.
12. Grodstein F., Stampfer M.J., Colditz G.A., Walter B.S., Wilett W.C., Manson J.E., Joffe M., Rosner B., Fuchs C., Hansinson S.E., Hunter D.J., Hennekens C.H., Speizer F.E. Postmenopausal hormone therapy and mortality. N Engl J Med. 336(25):1997;1769-1775.
13. A1C) with a cation exchange (mono-S) method (Academic Dissertation). University of Gothenburg, Gothenburg.
14. Jensen T., Bjerre-Knudsen J., Feldt-Rasmussen B., Deckert T. Features of endothelial dysfunction in early diabetic nephropathy. Lancet. 4:1989;461-463.
15. Jensen-Urstad K.J., Reichard P.G., Rosfors J.S., Lindblad L.-E.L., Jensen-Urstad M.T. Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM. Diabetes. 45:1996;1253-1258.
16. Jern C., Selin L., Jern S. In vivo release of tissue-type plasminogen activator across the human forearm during mental stress. Thromb Haemostasis. 72:1994;285-291.
17. Jern S., Selin L., Bergbrant A., Jern C. Release of tissue-type plasminogen activator in response to muscarinic receptor stimulation in human forearm. Thromb Haemostasis. 72:1995;588-594.
18. Johansson S., Vedin A., Wilhelmsson C. Myocardial infarction in women. Epidemiol Rev. 5:1983;67-95.
19. Johnstone M.T., Creager S.J., Scales K.M., Cusco J.A., Lee B.K., Creager M.A. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 88:1993;2510-2516.
20. Kannel W.B., Wilson W.F. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med. 155:1995;57-61.
21. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 18(2):1995;258-268.
22. Krolewski A.S., Kosinski E.J., Warram J.H., Leland O.S., Busick E.J., Asmal A.C., Rand L.I., Christleib A.R., Bradley R.F., Kahn C.R. Magnitude and determinants of coronary artery disease in juvenile-onset insulin-dependent diabetes mellitus. Am J Cardiol. 59:1987;750-755.
23. Kuusisto J., Mykkänen L., Pyörälä K., Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes. 43:1994;960-967.
24. Laakso M., Ronnemaa T., Lehto S., Puukka P., Kallio V., Pyörälä K. Does NIDDM increase the risk for coronary heart disease similarly in both low- and high-risk populations? Diabetologia. 38(4):1995;487-493.
25. Lekakis J., Papamichael C., Anastasiou H., Aleviazaki M., Desse N., Souvatzoglou A., Stamatelopoulos S., Koutras D.A. Endothelial dysfunction of conduit arteries in insulin-dependent diabetes mellitus without microalbuminuria. Cardiovasc Res. 34:1997;164-168.
26. Mäkimattila S., Mäntysaari M., Groop P.H., Summanen P., Vikamäki A., Schlenzka A., Fagerudd J., Yki-Järvinen H. Hyperreactivity to nitrovasodilators in forearm vasculature is related to autonomic dysfunction in insulin-dependent diabetes mellitus. Circulation. 95:1997;618-625.
27. Manson J.E., Colditz G.A., Stampfer M.J., Willet W.A., Krolewski A.S., Rosner B., Arky R.A., Speizer F.E., Hennekens C.H. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med. 151:1991;1141-1147.
28. McVeigh G.E., Brennan G.M., Johnston G.D., McDermott B.J., McGrarth L.T., Henry W.R., Andrews J.W., Hayes J.R. Impaired endothelium-dependent and independent vasodilation in patients with Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 35:1992;771-776.
29. Nitenberg A., Valensi P., Sachs R., Dali M., Aptecar E., Attali J.-R. Impairment of coronary vascular reserve and Ach-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes. 42:1993;1017-1025.
30. Petersen L.C., Handest P., Brender J., Selmer J., Jörgensen M., Thorsen S. A sensitive solid-phase immunosorbent assay for tissue-type plasminogen activator activity in plasma using trinitrobenzoylated poly-D-lysin as a stimulator for plasminogen activation. Thromb Haemostasis. 57:1995;205-211.
31. Poston L., Taylor P.D. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin Sci. 88:1995;245-255.
32. Rånby M., Nguyen G., Scarabin P.Y., Samama M. Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Thromb Haemostasis. 61:1989;409-414.
33. Sattar N., Jaap A.J., MacCuish A.C. Hormone replacement therapy and cardiovascular risk in postmenopausal women with NIDDM. Diabetes Med. 13:1996;782-788.
34. Sivertsson R. The hemodynamic importance of structural vascular changes in essential hypertension. Acta Med Scand, Suppl. 343:1995;1-56.
35. Taddei S., Virdis A., Ghiadoni L., Mattei P., Sudano I., Bernini G., Pinto S., Salvetti A. Menopause is associated with endothelial dysfunction in women. Hypertension. 28:1996;576-582.
36. The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 329:1993;977-986.
37. Vervoort G., Wetzels J.F.M., Lutterman J.A., Lenders J.W.M., Berden L.H.M., Smits P. Elevated Skeletal Muscle Flow in Non-complicated Type Diabetes: The Role of Nitric Oxide and Sympathetic Tone. 1998;International Society of Hypertension, Amsterdam. Abstract P21.02.
38. Watts G.F., O'Brien S.F., Silvester W., Millar J.A. Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidemia. Clin Sci. 91:1996;567-573.
39. Williams S.B., Cusco J.A., Roddy M.A., Johnstone M.T., Creager M.A. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 27:1996;567-574.
40. Yamada K., Nakano H., Nakayama M., Miura Y., Nishimura M., Tsuchida H., Mimura N. Endothelium-dependent relaxation in peripheral vasculature and kidney of non-insulin-dependent diabetes mellitus. J Diabetes Compl. 9:1995;203-207.